Lily Li

Dr. Li is the Senior Director of Process and Platform Development of BioAnalytix. Previously, Dr. Li was Laboratory Director at Tandem Labs, New England, where she oversaw operations and built quality systems to support pharmaceutical DMPK and biomarker R&D from early discovery through clinical development. Before joining Tandem Labs, Dr. Li was the Director of Analytics, Mass Spectrometry and the Founding Scientist at Cantata Pharmaceuticals, where she launched a biomarker-based CLIA certified laboratory. As High Throughput Analytics Lead at Monsanto, she led teams and built biochemical profiling platforms which were used to support Monsanto company-wide Genomics pipeline and Biotech research projects. Dr. Li is a co-author on several patents in methods and processes of small and large molecules analysis. Dr. Li was an NIH post-doctoral fellow in Drug Testing and Toxicology and received her Ph.D. in Food Chemistry at Cornell University. She earned her M.S. in Nutritional Biochemistry at University of Illinois, Urbana-Champaign.